Automated Multi-Modal MRI Segmentation of Stroke Lesions and Corticospinal Tract Integrity for Functional Outcome Prediction

Identificador:  imarina:9525596

Handle: https://hdl.handle.net/20.500.11797/imarina9525596

Autores:  Iqbal, Daniyal; Puig, Domenec; Mursil, Muhammad; Rashwan, Hatem A

Resumen:
Background/Objectives: Stroke is a leading cause of long-term disability, and predicting functional outcome at discharge, such as the modified Rankin Scale (mRS), is important for guiding treatment and rehabilitation. Many existing approaches depend on advanced imaging or complex corticospinal tract (CST) segmentation from multi-shell diffusion MRI, limiting clinical feasibility. Automated lesion segmentation is also challenging due to lesion heterogeneity and MRI variability. This study proposes a clinically feasible multimodal MRI pipeline based on routine imaging. Methods: Lesion segmentation models were trained and evaluated on the ISLES 2022 dataset (250 training, 150 test cases). Zero-shot external evaluation was performed on 149 cases from ISLES 2024 using standard MRI sequences only. An ensemble of deep learning models (SEALS, NVAUTO, FACTORIZER) was evaluated on ISLES 2022, while SEALS alone was used for external testing. CST segmentation was performed using TractSeg on single-shell diffusion-weighted imaging. Imaging biomarkers included lesion volume, shape, ADC-based texture features, CST integrity, and lesion-CST overlap. These features were used to train machine learning models for binary mRS prediction at discharge. Results: The ensemble achieved a Dice score of 0.82 on ISLES 2022, while zero-shot evaluation on ISLES 2024 achieved 0.57. In exploratory analysis, CatBoost achieved the highest point estimates (accuracy 0.88, F1-score 0.87, ROC-AUC 0.83). Key predictors included lesion-CST overlap, lesion volume, surface area, dissimilarity, and contrast. Conclusions: This exploratory study demonstrates the feasibility of combining automated lesion segmentation with anatomically informed biomarkers using routine clinical MRI, supporting interpretable stroke outcome modelling and motivating future large-scale validation.